Inovio Pharmaceuticals Inc (NASDAQ:INO)

8.50
Delayed Data
As of 4:54pm ET
 -0.32 / -3.63%
Today’s Change
5.81
Today|||52-Week Range
33.79
-3.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues40.6M35.4M42.2M30.5M
 
 
 
 
 
Depreciation And Amortization1.9M3.1M3.5M5.0M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses73.9M109.5M123.4M119.6M
 
 
 
 
 
Research And Development57.8M88.7M98.6M95.3M
 
 
 
 
 
Total Operating Expenses75.9M112.6M126.9M124.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-35.3M-77.2M-84.6M-94.1M
 
 
 
 
 
Extraordinary Credit2.8M1.2M806.8K360.8K
 
 
 
 
 
Extraordinary Charge-274.0K0.000.000.00
 
 
Other Expenses1.6M2.3M-4.4M-1.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-31.2M-73.7M-88.2M-94.8M
 
 
 
 
 
Income Taxes-2.1M0.000.00-2.2M
 
 
 
Minority Interest-84.8K0.000.000.00
 
 
Net Income-29.2M-73.7M-88.2M-97.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS68.2M73.2M81.8M92.5M
 
 
 
 
 
Shares To Calculate EPS Diluted68.4M73.2M81.9M92.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.44-$1.01-$1.09-$1.05
 
 
 
 
 
EPS Diluted-$0.44-$1.01-$1.09-$1.05